News | Optical Coherence Tomography (OCT) | September 27, 2016

Avinger Signs Agreement with U.S. Department of Veterans Affairs for Lumivascular Technology

Contract award covers Avinger’s full range of optical coherence tomography-based products

Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award

September 27, 2016 — Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans Affairs (VA). The award establishes terms under which VA hospitals across the country may acquire Avinger’s Lumivascular portfolio of optical coherence tomography (OCT) image-guided catheters for their veterans hospitals.

VA operates the nation's largest integrated healthcare system, with more than 1,700 hospitals, clinics, community living centers, domiciliaries, readjustment counseling centers and other facilities.

Avinger’s current Lumivascular products include the Lightbox OCT imaging console, the Ocelot family of catheters — which are designed to penetrate total arterial blockages, known as chronic total occlusions (CTOs) — and Pantheris, the first-ever image-guided atherectomy device, designed to precisely remove arterial plaque in peripheral artery disease (PAD) patients.

For more information: www.avinger.com

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init